443 related articles for article (PubMed ID: 18844613)
1. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis.
Lucendo AJ; De Rezende L; Comas C; Caballero T; Bellón T
Am J Gastroenterol; 2008 Sep; 103(9):2184-93. PubMed ID: 18844613
[TBL] [Abstract][Full Text] [Related]
2. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids.
Blanchard C; Mingler MK; Vicario M; Abonia JP; Wu YY; Lu TX; Collins MH; Putnam PE; Wells SI; Rothenberg ME
J Allergy Clin Immunol; 2007 Dec; 120(6):1292-300. PubMed ID: 18073124
[TBL] [Abstract][Full Text] [Related]
3. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis.
Bullock JZ; Villanueva JM; Blanchard C; Filipovich AH; Putnam PE; Collins MH; Risma KA; Akers RM; Kirby CL; Buckmeier BK; Assa'ad AH; Hogan SP; Rothenberg ME
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):22-31. PubMed ID: 17592361
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease.
Bhattacharya B; Carlsten J; Sabo E; Kethu S; Meitner P; Tavares R; Jakate S; Mangray S; Aswad B; Resnick MB
Hum Pathol; 2007 Dec; 38(12):1744-53. PubMed ID: 17900656
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
Park CW; Lee BH; Han HJ; Lee CH; Ahn HK
Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
[TBL] [Abstract][Full Text] [Related]
6. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.
Konikoff MR; Blanchard C; Kirby C; Buckmeier BK; Cohen MB; Heubi JE; Putnam PE; Rothenberg ME
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1328-36. PubMed ID: 17059896
[TBL] [Abstract][Full Text] [Related]
7. Infiltrating eosinophils and eotaxin: their association with idiopathic eosinophilic esophagitis.
Fujiwara H; Morita A; Kobayashi H; Hamano K; Fujiwara Y; Hirai K; Yano M; Naka T; Saeki Y
Ann Allergy Asthma Immunol; 2002 Oct; 89(4):429-32. PubMed ID: 12392390
[TBL] [Abstract][Full Text] [Related]
8. Analysis of eotaxin 1/CCL11, eotaxin 2/CCL24 and eotaxin 3/CCL26 expression in lesional and non-lesional skin of patients with atopic dermatitis.
Owczarek W; Paplińska M; Targowski T; Jahnz-Rózyk K; Paluchowska E; Kucharczyk A; Kasztalewicz B
Cytokine; 2010 May; 50(2):181-5. PubMed ID: 20236835
[TBL] [Abstract][Full Text] [Related]
9. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.
Stein ML; Collins MH; Villanueva JM; Kushner JP; Putnam PE; Buckmeier BK; Filipovich AH; Assa'ad AH; Rothenberg ME
J Allergy Clin Immunol; 2006 Dec; 118(6):1312-9. PubMed ID: 17157662
[TBL] [Abstract][Full Text] [Related]
10. Mucosal cytokine profiles in paediatric eosinophilic oesophagitis: a case-control study.
Romano C; Chiaro A; Lucarelli S; Santarelli C; Cucchiara S; Guadagnini T; Miele E; Di Nardo G
Dig Liver Dis; 2014 Jul; 46(7):590-5. PubMed ID: 24704289
[TBL] [Abstract][Full Text] [Related]
11. Quantitative expression levels of regulated on activation, normal T cell expressed and secreted and eotaxin transcripts in toluene diisocyanate-induced allergic rats.
Im GJ; Hwang CS; Jung HH
Acta Otolaryngol; 2005 Apr; 125(4):370-7. PubMed ID: 15823807
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human eotaxin-3/CCL26 expression: modulation by cytokines and glucocorticoids.
Banwell ME; Tolley NS; Williams TJ; Mitchell TJ
Cytokine; 2002 Mar; 17(6):317-23. PubMed ID: 12061839
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus.
Lucendo AJ; Navarro M; Comas C; Pascual JM; Burgos E; Santamaría L; Larrauri J
Am J Surg Pathol; 2007 Apr; 31(4):598-606. PubMed ID: 17414108
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia.
Jahnsen FL; Haye R; Gran E; Brandtzaeg P; Johansen FE
J Immunol; 1999 Aug; 163(3):1545-51. PubMed ID: 10415058
[TBL] [Abstract][Full Text] [Related]
16. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis.
Gupta SK; Fitzgerald JF; Kondratyuk T; HogenEsch H
J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):22-6. PubMed ID: 16385249
[TBL] [Abstract][Full Text] [Related]
17. BAL eotaxin and IL-5 in asthma, and the effects of inhaled corticosteroid and beta2 agonist.
Feltis BN; Reid DW; Ward C; Walters EH
Respirology; 2004 Nov; 9(4):507-13. PubMed ID: 15612963
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.
Shin SH; Park JY; Jeon CH; Choi JK; Lee SH
Laryngoscope; 2000 Aug; 110(8):1353-7. PubMed ID: 10942140
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J; Jiang F; Nayeri F; Zetterström O
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[TBL] [Abstract][Full Text] [Related]
20. Induction of eotaxin production by interleukin-4, interleukin-13 and lipopolysaccharide by nasal fibroblasts.
Nonaka M; Pawankar R; Fukumoto A; Ogihara N; Sakanushi A; Yagi T
Clin Exp Allergy; 2004 May; 34(5):804-11. PubMed ID: 15144475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
